Sales rise 9.71% to Rs 30.06 crore
Net profit of Jenburkt Pharmaceuticals rose 58.07% to Rs 5.58 crore in the quarter ended March 2018 as against Rs 3.53 crore during the previous quarter ended March 2017. Sales rose 9.71% to Rs 30.06 crore in the quarter ended March 2018 as against Rs 27.40 crore during the previous quarter ended March 2017.For the full year,net profit rose 27.39% to Rs 17.21 crore in the year ended March 2018 as against Rs 13.51 crore during the previous year ended March 2017. Sales rose 11.00% to Rs 114.67 crore in the year ended March 2018 as against Rs 103.31 crore during the previous year ended March 2017.
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales30.0627.40 10 114.67103.31 11 OPM %28.3120.73 -20.7419.09 - PBDT9.036.44 40 26.7622.27 20 PBT8.655.99 44 25.2620.48 23 NP5.583.53 58 17.2113.51 27
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
